Kaskela Law LLC announces that it is investigating Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) on behalf of the company’s shareholders.

Since January 2024, shares of Inari’s common stock have declined in value from a trading price of over $65.00 per share to a current trading price of approximately $41.00 per share, a decline of over $24.00 per share, or approximately 37% in value.

The investigation seeks to determine whether Inari and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s shareholders.

Inari shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options.